Citation Impact
Citing Papers
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
2016 Standout
Factors Associated With Severe Late Toxicity After Concurrent Chemoradiation for Locally Advanced Head and Neck Cancer: An RTOG Analysis
2008 Standout
Cisplatin-induced renal toxicity and toxicity-modulating strategies: a review
1994
Pulmonary rehabilitation in chronic respiratory insufficiency. 5. Home mechanical ventilation.
1993
Radioprotective action of curcumin extracted from Curcuma longa LINN: inhibitory effect on formation of urinary 8-hydroxy-2′-deoxyguanosine, tumorigenesis, but not mortality, induced by γ-ray irradiation
2002
A prospective randomized placebo-controlled double-blinded pilot study of misoprostol rectal suppositories in the prevention of acute and chronic radiation proctitis symptoms in prostate cancer patients
2000
Topical or Systemic 16,16 Dm Prostaglandin E2or WR-2721 (WR-1065) Protects Mice from Alopecia after Fractionated Irradiation
1992
Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults
2007 Standout
Practice Guidelines for the Management of Community-Acquired Pneumonia in Adults
2000 Standout
Curcumin, the Golden Spice From Indian Saffron, Is a Chemosensitizer and Radiosensitizer for Tumors and Chemoprotector and Radioprotector for Normal Organs
2010 Standout
Perspectives on cancer therapy-induced mucosal injury
2004 Standout
Chemotherapy for malignant gliomas
1988
An integrative model of shared decision making in medical encounters
2005 Standout
Cisplatin: mode of cytotoxic action and molecular basis of resistance
2003 Standout
Predicting Death in Patients Hospitalized for Community-acquired Pneumonia
1991
Recursive partitioning analysis (RPA) of prognostic factors in three radiation therapy oncology group (RTOG) brain metastases trials
1997 Standout
Amifostine
2001
A Prediction Rule to Identify Low-Risk Patients with Community-Acquired Pneumonia
1997 Standout
Oxidative stress, redox regulation and diseases of cellular differentiation
2014
Nutrition and physical activity guidelines for cancer survivors
2012 Standout
Amifostine in clinical oncology: current use and future applications
2002
Molecular mechanisms of resistance and toxicity associated with platinating agents
2006 Standout
Amifostine pretreatment for protection against cyclophosphamide-induced and cisplatin-induced toxicities: results of a randomized control trial in patients with advanced ovarian cancer.
1996
Curcumin as “Curecumin”: From kitchen to clinic
2007 Standout
TNF-α mediates chemokine and cytokine expression and renal injury in cisplatin nephrotoxicity
2002 Standout
Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study
2003 Standout
Cisplatin Nephrotoxicity: A Review
2007 Standout
Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: A systematic review and meta-analysis
2014 Standout
Protecting against anthracycline‐induced myocardial damage: a review of the most promising strategies
2005
Block copolymer micelles for drug delivery: design, characterization and biological significance
2001 Standout
Effect of a Protective-Ventilation Strategy on Mortality in the Acute Respiratory Distress Syndrome
1998 Standout
Toxicity of platinum compounds
2003
The importance of antioxidants which play the role in cellular response against oxidative/nitrosative stress: current state
2015 Standout
Curcumin: The story so far
2005 Standout
Protection from toxicant-mediated renal injury in the rat with anti-CD54 antibody
1999
Hematopoietic stem cell compartment: Acute and late effects of radiation therapy and chemotherapy
1995
Biochemical modulation of cisplatin toxicity
1989
Should Supplemental Antioxidant Administration Be Avoided During Chemotherapy and Radiation Therapy?
2008
The pathobiology of mucositis
2004 Standout
Cisplatin: The first metal based anticancer drug
2019 Standout
Newer Insights into Cisplatin Nephrotoxicity
1993
Cisplatin in cancer therapy: Molecular mechanisms of action
2014 Standout
Phase III multicenter randomized trial of amifostine as cytoprotectant in first-line chemotherapy in ovarian cancer patients
2003
The APACHE III Prognostic System
1991 Standout
Pharmacokinetics of amifostine and its metabolites in patients
1997
Anthracycline-induced cardiotoxicity: Overview of studies examining the roles of oxidative stress and free cellular iron
2009 Standout
CURCUMIN: THE INDIAN SOLID GOLD
2007 Standout
Radioprotection of the rat small intestine with topical WR-2721
1994
Amifostine as Radioprotective Agent for the Rectal Mucosa during Irradiation of Pelvic Tumors
2003
What Do Physicians Tell Patients With End-Stage COPD About Intubation and Mechanical Ventilation?
1996
WR2721 as a modulator of cisplatin-and carboplatin-induced side effects in comparison with other chemoprotective agents: a molecular approach
1993
Anticancer Drug???Induced Kidney Disorders
2001
Guidelines for the Management of Adults with Community-acquired Pneumonia
2001 Standout
Outreach Education to Improve Quality of Rural ICU Care
1998
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2012 Standout
Audit and feedback: effects on professional practice and healthcare outcomes
2012 Standout
Interventions for preventing neuropathy caused by cisplatin and related compounds
2014
Prevention of High-Dose Chemotherapy–Induced Cardiotoxicity in High-Risk Patients by Angiotensin-Converting Enzyme Inhibition
2006 Standout
TNF-α mediates chemokine and cytokine expression and renal injury in cisplatin nephrotoxicity
2002 Standout
Childhood and adolescent cancer statistics, 2014
2014 Standout
Determination of Antioxidants by DPPH Radical Scavenging Activity and Quantitative Phytochemical Analysis of Ficus religiosa
2022 Standout
ICRP PUBLICATION 118: ICRP Statement on Tissue Reactions and Early and Late Effects of Radiation in Normal Tissues and Organs — Threshold Doses for Tissue Reactions in a Radiation Protection Context
2012 Standout
Anticancer potential of curcumin: preclinical and clinical studies.
2003 Standout
Tailored interventions to address determinants of practice
2015 Standout
Current Status of Platinum-Based Antitumor Drugs
1999 Standout
Aggregation-Induced Emission: Together We Shine, United We Soar!
2015 Standout
Mechanisms of Cisplatin Nephrotoxicity
2010 Standout
Amifostine: chemotherapeutic and radiotherapeutic protective effects
2001
A randomized phase iii protocol for the evaluation of misonidazole combined with radiation in the treatment of patients with brain metastases (RTOG-7916)
1991
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
2014 Standout
Complications of assisted ventilation
1974
Utilization Strategies for Intensive Care Units
1989
Gene correction in hematopoietic progenitor cells by homologous recombination
2000 StandoutNobel
Turmeric (Curcuma longa) and its major constituent (curcumin) as nontoxic and safe substances: Review
2018 Standout
Complications and consequences of endotracheal intubation and tracheotomy
1981 Standout
Prostaglandins protect against murine hair injury produced by ionizing radiation or doxorubicin
1993
Long-term Cardiovascular Toxicity in Children, Adolescents, and Young Adults Who Receive Cancer Therapy: Pathophysiology, Course, Monitoring, Management, Prevention, and Research Directions
2013
Amifostine: The First Selective-Target and Broad-Spectrum Radioprotector
2007
The Chemistry of Neutron Capture Therapy
1998 Standout
Community acquired pneumonia: aetiology and usefulness of severity criteria on admission.
1996
Neurotoxicity Caused by the Treatment with Platinum Analogues
2011
Early Detection of Anthracycline Cardiotoxicity and Improvement With Heart Failure Therapy
2015 Standout
New Therapies for Ovarian Cancer
1992
The current status of new platinum analogs.
1992
Works of Clare Weiler being referenced
Phase I/II trials of WR-2721 and cis-platinum
1986
Clinical trials of WR-2721 and cis-platinum
1989
Clinical trials of WR-2721 prior to alkylating agent chemotherapy and radiotherapy
1988
Impact of the Respiratory Intensive Care Unit on Survival of Patients with Acute Respiratory Failure
1972
Phase I Controlled trials of WR-2721 and cyclophosphamide
1984
Human pharmacokinetics of WR-2721
1986
Misonidazole and radiotherapy to treat malignant glioma: A phase II trial of the radiation therapy oncology group
1981
Phase I trials of WR-2721 and cis-platinum
1984